Aqr Ms Fusion Hv Fund Class R6 (QHFRX)

What a load! You never answered why you bash Biel all the time. Come clean....is there some sort of financial incentive for you? People visiting this board are entitled to know. Go Biel!

The DD keeps adding up!!!! 

Crazy.
The truth will come out with a vengeance.

https://media.licdn.com/dms/image/v2/D5622AQHpdrCru1Ls7A/feedshare-shrink_1280/B56Z66UIaVHUAQ-/0/1781242300341?e=1785369600&v=beta&t=KTR5Wdn9_tDL7FDXM_TikQYmLzWL8pwLl5_8naFgZ-M

LG

I think we are finally on to something here..60 days to possible liftoff.. lol and by the way how many co.mons outstanding and your estimate of $/sh from. RE?

manibiotech,

I am waiting just like everyone else but unlike some here that get disappointed by every theory that falls flat I am focused on what really matters for the company and patients which is availability by way of affordability via manufacturing transition to Flaskworks. I wa

More than one "someone". They can't keep it secret forever....there's too much money involved, and someone will eventually get greedy and make a mistake, exposing who is setting up and running these serial scams. It'll probably end up being a familiar face, and in plain sight too.

Doc, if you're asking about Dr. Annalisa Jenkins' association with TMC Pharma I don't know and have not looked for any such association...

AI farmed response for sure. Easy enough to spot. I will say AI is brilliant at interior design…other things not so much.

I remember a few people saying it would be a few weeks (maybe even by Christmas 2025) that the COB would come through after the shareholders vote in November. And than we all we waited 7 months to find out they pulled themselves out of the exchange entirely.This thing is turning into a bit of a disa

DJknows,

Any connections to the big gun new hire by NWBO? Best wishes.

Read this
https://firstwordpharma.com/story/7134811

Holding Company holding NOTHING OF VALUE

It’s only a share selling scam

https://investorshub.advfn.com/uimage/uploads/2026/1/24/ttuxiIMG_0148.jpeg

Someone knows who is behind the mess.

Becky Willoughby is Senior Director, Regulatory Services at TMC Pharma Services Ltd. since July of last year according to her LinkedIn account:

https://www.linkedin.com/in/becky-willoughby/

While there's no public confirmation TMC Pharma EU serves as the designated Mark

agreed. the ss on this is great compared to most out there. 

Holding Company holding NOTHING OF VALUE

It’s only a share selling scam

https://investorshub.advfn.com/uimage/uploads/2026/1/24/ttuxiIMG_0148.jpeg

FormalMHRAconsultant,

Just a reminder, “…rested on the weaker cohort-level method” is a now proven false claim BECAUSE of the way this data was assembled and checked down on using a method that Dr. Linda Liau helped put together so that NWBO could move forward with their SAP while wai

Actually Wade Huettel and Luis Carillo were the attorneys for SRGE. Not sure of the link to Zouvas.

All seem to have a S. California link, even down to being in San Diego.

https://finance.yahoo.com/news/wave-bell-id-partner-combat-123000246.html

This press release sounds REALLY COOL!!! Bill Solms did some GREAT THINGS with Wave!!! A lot of older GREAT Wave projects could be resurrected IMO since the TPM is ubiquitous now!!!!

I'm reasonably sure the transfer agent is a crossover too. CRGP I think.

"feds learned from the financial crisis of 2008 that they can print trillions if they need to rescue big banks..."

That's nice to know. So, do you know when the FDIC is going to resolve and terminate WaMu's Receivership???
MANY Legacy shareholders signed releases and would like

Hey, a little counseling and I think you two could work this out in no time. I'm rooting for ya's! LOL
" I hear that train a coming. It's coming round the bend"
GET SOME BABY.....SOON!

I've always marveled at the connection between the attorneys for those three scams. You can bet there was lots of teamwork setting up these very similar scams.

Applbaum & Zouvas was a boutique law firm in San Diego, California, founded by attorneys Marc Applbaum and Luke Zouvas. T